Featured Research

from universities, journals, and other organizations

Stopping liver failure from common painkiller overdose

Date:
February 4, 2014
Source:
University of Adelaide
Summary:
Researchers have identified a key step for the future prevention of liver failure resulting from taking too much of the everyday painkiller acetaminophen (also known as paracetamol).

University of Adelaide researchers have identified a key step for the future prevention of liver failure resulting from taking too much of the everyday painkiller paracetamol (also known as acetaminophen).

Related Articles


Published today in the Proceedings of the National Academy of Sciences (PNAS), the study pinpoints a target for new treatments to prevent the potentially lethal consequences of paracetamol overdose.

"Paracetamol is the most frequently used over-the-counter pain medication," says Dr Grigori Rychkov, Senior Research Fellow in the University's School of Medical Sciences.

"Overdose of paracetamol is the most common cause of acute liver failure and the leading cause of liver damage requiring transplantation in developed countries. The precise mechanisms of liver toxicity due to paracetamol overdose, however, have remained unclear."

It has been known for a long time that paracetamol overdose is associated with toxic levels of calcium in liver cells but nobody has known how the calcium gets into the cells.

The University of Adelaide researchers have identified a channel transporting calcium across the cell membrane that is triggered by paracetamol overdose, known as Transient Receptor Potential Melanostatine2 (TRPM2). Once the channel is activated, the cells become overloaded with calcium, leading to cell death. If this continues and enough cells die, it can lead to liver failure.

The research, conducted by PhD student Ehsan Kheradpezhouh, showed in laboratory studies that when the TRPM2 channel was missing or blocked, liver cells were protected from paracetamol damage.

"We now have a potential drug target for treating paracetamol overdose and possibly some other liver-damaging poisonings," says Dr Rychkov.

Currently paracetamol overdose can be effectively treated -- but only if caught within 18 hours.

"If we can block the TRPM2 channel we might be able to prevent the toxicity or extend this timeframe. If we can stop the calcium uptake and cell death, we'll be giving the liver a better chance for recovery and, hopefully, preventing complete liver failure," says Dr Rychkov.


Story Source:

The above story is based on materials provided by University of Adelaide. Note: Materials may be edited for content and length.


Journal Reference:

  1. E. Kheradpezhouh, L. Ma, A. Morphett, G. J. Barritt, G. Y. Rychkov. TRPM2 channels mediate acetaminophen-induced liver damage. Proceedings of the National Academy of Sciences, 2014; DOI: 10.1073/pnas.1322657111

Cite This Page:

University of Adelaide. "Stopping liver failure from common painkiller overdose." ScienceDaily. ScienceDaily, 4 February 2014. <www.sciencedaily.com/releases/2014/02/140204101416.htm>.
University of Adelaide. (2014, February 4). Stopping liver failure from common painkiller overdose. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2014/02/140204101416.htm
University of Adelaide. "Stopping liver failure from common painkiller overdose." ScienceDaily. www.sciencedaily.com/releases/2014/02/140204101416.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins